BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4311236)

  • 1. Plasma insulin: fluctuations in the "big" insulin component in man after glucose and other stimuli.
    Gorden P; Roth J
    J Clin Invest; 1969 Dec; 48(12):2225-34. PubMed ID: 4311236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proinsulin-like component of circulating insulin in the basal state and in patients and hamsters with islet cell tumors.
    Gorden P; Sherman B; Roth J
    J Clin Invest; 1971 Oct; 50(10):2113-22. PubMed ID: 4330005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human serum proinsulin.
    Melani F; Rubenstein AH; Steiner DF
    J Clin Invest; 1970 Mar; 49(3):497-507. PubMed ID: 5461203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of insulin and glucose in the induction of hypoaminoacidemia in man: studies in normal, juvenile diabetic, and insuloma patients.
    Adibi SA; Morse EL; Amin PM
    J Lab Clin Med; 1975 Sep; 86(3):395-409. PubMed ID: 168278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating insulin: th proinsulin-like properties of "big" insulin in patients withou islet cell tumors.
    Sherman BM; Gorden P; Roth J; Freychet P
    J Clin Invest; 1971 Apr; 50(4):849-58. PubMed ID: 4323127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperproinsulinaemia in acromegaly: evidence for abnormal pancreatic beta-cell function?
    Gama R; Teale JD; Wright J; Ferns G; Marks V
    Ann Clin Biochem; 1997 Nov; 34 ( Pt 6)():627-31. PubMed ID: 9366999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonautonomous function of a pancreatic insulinoma.
    Rayfield EJ; Pulini M; Golub A; Rubenstein AH; Horwitz DL
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1307-11. PubMed ID: 187613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energy metabolism and substrate oxidation in acromegaly.
    O'Sullivan AJ; Kelly JJ; Hoffman DM; Baxter RC; Ho KK
    J Clin Endocrinol Metab; 1995 Feb; 80(2):486-91. PubMed ID: 7852509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of plasma insulin to small doses of tolbutamide in obesity and acromegaly.
    Pelkonen R; Taskinen MR; Nikkilä EA
    Int J Obes; 1977; 1(4):315-24. PubMed ID: 617112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance.
    Robertson DA; Singh BM; Nattrass M
    Int J Obes; 1991 Oct; 15(10):635-45. PubMed ID: 1752724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. II. Pancreatic vein immunoreactive insulin in dogs (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1975 Aug; 51(8):685-92. PubMed ID: 1237422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin, proinsulin, glucagon and gastrin in pancreatic tumors and in plasma of patients with organic hyperinsulinism.
    Hayashi M; Floyd JC; Pek S; Fajans SS
    J Clin Endocrinol Metab; 1977 Apr; 44(4):681-94. PubMed ID: 14970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects.
    Bagdade JD; Bierman EL; Porte D
    J Clin Invest; 1967 Oct; 46(10):1549-57. PubMed ID: 6061732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of A and B cell functions by tolbutamide and arginine in the pancreas of thiamine-deficient rats.
    Rathanaswami P; Sundaresan R
    Biochem Int; 1989 Oct; 19(4):793-802. PubMed ID: 2695088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly.
    Hattori N; Shimatsu A; Kato Y; Koshiyama H; Ishikawa Y; Assadian H; Tanoh T; Nagao M; Imura H
    J Clin Endocrinol Metab; 1990 Mar; 70(3):771-6. PubMed ID: 2106529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute suppressive effect of human growth hormone on insulin release induced by glucagon and tolbutamide in man.
    Adamson U; Cerasi E
    Diabete Metab; 1975 Mar; 1():51-6. PubMed ID: 1234067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct measurement of proinsulin in human plasma by the use of an insulin-degrading enzyme.
    Kitabchi AE; Duckworth WC; Brush JS; Heinemann M
    J Clin Invest; 1971 Sep; 50(9):1792-9. PubMed ID: 4327576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improvement in glucose tolerance and insulin sensitivity after a single administration of tolbutamide in hypertensive patients].
    Dzúrik R; Dzúriková K; Spustová V
    Vnitr Lek; 1991 Mar; 37(3):255-60. PubMed ID: 2031314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic effects of short-term fasting in obese hyperglycaemic humans and mice.
    Belfiore F; Iannello S; Rabuazzo AM; Campione R
    Int J Obes; 1987; 11(6):631-40. PubMed ID: 2831163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.